John C. Compton's most recent trade in 20/20 Biolabs Inc was a trade of 7,669 Common Stock done . Disclosure was reported to the exchange on Feb. 19, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| 2020 Biolabs Inc | John G Compton | Director | 19 Feb 2026 | 7,669 | 14,335 | - | 0 | Common Stock | ||
| 2020 Biolabs Inc | John G Compton | Director | 19 Feb 2026 | 7,669 | 0 | - | - | Series A-2 Preferred Stock | ||
| First Horizon Corp | John C. Compton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2025 | 15,588 | 164,786 (0%) | 0% | 0 | Common Stock | |
| First Horizon Corp | John C. Compton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2024 | 18,829 | 149,198 (0%) | 0% | 0 | Common Stock | |
| First Horizon Corp | John C. Compton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 6,955 | 130,369 (0%) | 0% | 0 | Common Stock | |
| First Horizon Corp | John C. Compton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 10,251 | 123,414 (0%) | 0% | 0 | Common Stock | |
| First Horizon Corp | John C. Compton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2021 | 12,506 | 113,163 (0%) | 0% | 0 | Common Stock |